查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1842016

美国动静脉瘻管装置市场：市场规模、份额、趋势分析（按类型和最终用途划分）、细分市场预测（2025-2033 年）

U.S. Arteriovenous Fistula Devices Market Size, Share & Trends Analysis Report By Type, By End-use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

美国动静脉瘻管器械市场摘要

据估计，2024 年美国动静脉瘻管装置市值为 1.11 亿美元，预计到 2033 年将达到 1.2 亿美元，2025 年至 2033 年的复合年增长率为 0.9%。

这一增长是由多种因素驱动的，包括末期肾功能衰竭(ESRD) 的患病率不断上升以及由此导致的需要血液透析机的患者人数增加。

先进的医疗基础设施、糖尿病和高血压的高发病率以及美国广泛的意识提升提升预计将推动市场成长。根据美国疾病管制与预防中心 (CDC) 2023 年的估计，美国约有 14% 的成年人患有慢性肾臟病(CKD)。此外，根据美国肾臟基金会的报告，目前约有 81.5 万美国患有肾衰竭，其中约 55.5 万人正在接受透析治疗。

肾臟捐赠者严重短缺导致透析依赖性增加，凸显了动静脉瘻管（AVF）装置在末期肾臟病（ESRD）治疗中的关键作用。肾臟疾病的增加也推动了对更先进、更具创新性的AVF解决方案的需求。与其他存取类型相比，AVF具有耐用性强、感染率低、併发症风险低等优点，因此是长期血管通路的首选。这些因素正在推动AVF在美国的快速发展。

动静脉移植（AVG）和中央静脉导管（CVC）是血液血液透析机中除动静脉瘻管（AVF）以外的两种主要血管通路方式。通路方式的选择具有重要的临床和经济意义，并直接影响市场动态。 AVF因其感染率低、使用寿命长而被认为是黄金标准，但其成熟时间长、初始失败率高，因此需要寻找替代方案。

目录

第一章 分析方法和范围

第二章执行摘要

第三章美国动静脉瘻管器械市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场
    • 附随市场
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国动静脉瘻管器械市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL分析
    • 法律规范

第四章美国动静脉瘻管装置市场：按类型分類的估算与趋势分析

  • 细分仪表板
  • 美国动静脉瘻管装置市场：按类型分類的差异分析
  • 美国动静脉瘻管装置市场规模及趋势分析（按类型划分）（2021-2033 年）
    • AVF 创建设备
    • AVF监测设备
    • AVF维修装置

第五章美国动静脉瘻管设备市场：依最终用途分類的估算与趋势分析

  • 细分仪表板
  • 美国动静脉瘻管器械市场：依最终用途分類的差异分析
  • 美国动静脉瘻管装置市场规模及趋势分析（依最终用途划分）（2021-2033 年）
    • 医院
    • 门诊手术中心
    • 透析中心

第六章 竞争情势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 主要企业泥炭地分布图分析（2024 年）
  • 公司简介
    • Medtronic
    • BD
    • Teleflex Incorporated
    • Fresenius Medical Care
    • B. Braun Medical Inc.
    • Polymed
    • Laminate Medical Technologies Ltd.
    • Cook Group
    • Smiths Group plc
Product Code: GVR-4-68040-758-5

U.S. Arteriovenous Fistula Devices Market Summary

The U.S. arteriovenous fistula devices market size was estimated at USD 111.0 million in 2024 and is projected to reach USD 120.0 million by 2033, growing at a CAGR of 0.9% from 2025 to 2033. The growth is attributed to several factors, including the increasing prevalence rate of End-stage Renal Disease (ESRD) and the resulting rise in the number of patients requiring hemodialysis.

The advanced healthcare infrastructure, a high incidence of diabetes & hypertension, and widespread awareness initiatives in the country are expected to drive the market growth. According to 2023 estimates by the Centers for Disease Control and Prevention (CDC), approximately 14% of adults in the U.S. are affected by chronic kidney disease (CKD). Furthermore, the American Kidney Fund reports that approximately 815,000 Americans are currently living with kidney failure, with nearly 555,000 of them undergoing dialysis, highlighting the widespread need for effective treatment solutions.

Due to the critical shortage of kidney donors, the increasing dependence on dialysis underscores the essential role of AVF devices in managing ESRD. The escalating rate of kidney disease is also driving the demand for more advanced and innovative AVF solutions. AV fistulas are preferred for long-term vascular access because of their durability, lower infection rates, and reduced complication risk compared to other access types. These factors are propelling the growth of AVF devices in the U.S.

Two other types of vascular access for hemodialysis, arteriovenous graft (AVG) and central venous catheter (CVC), are the primary substitutes for an arteriovenous fistula. The choice of access has significant clinical and economic implications, directly impacting market dynamics. While AVFs are considered the gold standard due to lower infection rates and better longevity, their long maturation time and high primary failure rate make substitutes necessary.

U.S. Arteriovenous Fistula Devices Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. arteriovenous fistula devices market report based on type and end-use.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • AVF Creation Devices
    • Surgical Instruments
    • Vascular Grafts
    • Angioplasty Balloons
    • Others
  • AVF Monitoring Devices
    • Doppler Ultrasound
    • Pressure Monitoring Systems
    • Others
  • AVF Maintenance Devices
    • Central Venous Catheters
    • Stents
    • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers
  • Dialysis Centers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of primary research
  • 1.5. Information/Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. End Use Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Arteriovenous Fistula Devices Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. U.S. Arteriovenous Fistula Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
    • 3.3.3. Regulatory Framework

Chapter 4. U.S. Arteriovenous Fistula Devices Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Arteriovenous Fistula Devices Market: Type Movement Analysis
  • 4.3. U.S. Arteriovenous Fistula Devices Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
    • 4.3.1. AVF Creation Devices
      • 4.3.1.1. AVF Creation Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.2. Surgical Instruments
        • 4.3.1.2.1. Surgical Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.3. Vascular Grafts
        • 4.3.1.3.1. Vascular Grafts Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.4. Angioplasty Balloons
        • 4.3.1.4.1. Angioplasty Balloons Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.5. Others
        • 4.3.1.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. AVF Monitoring Devices
      • 4.3.2.1. AVF Monitoring Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.2. Doppler Ultrasound
        • 4.3.2.2.1. Doppler Ultrasound Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3. Pressure Monitoring Systems
        • 4.3.2.3.1. Pressure Monitoring Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.4. Others
        • 4.3.2.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. AVF Maintenance Devices
      • 4.3.3.1. AVF Maintenance Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.2. Central Venous Catheters
        • 4.3.3.2.1. Central Venous Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.3. Stents
        • 4.3.3.3.1. Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.4. Others
        • 4.3.3.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Arteriovenous Fistula Devices Market: By End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Arteriovenous Fistula Devices Market: By End Use Movement Analysis
  • 5.3. U.S. Arteriovenous Fistula Devices Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
    • 5.3.1. Hospitals
      • 5.3.1.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Ambulatory Surgical Centers
      • 5.3.2.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.3. Dialysis Centers
      • 5.3.3.1. Dialysis Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. Key company Heat Map Analysis, 2024
  • 6.4. Company Profiles
    • 6.4.1. Medtronic
      • 6.4.1.1. Company Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. BD
      • 6.4.2.1. Company Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Teleflex Incorporated
      • 6.4.3.1. Company Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. Fresenius Medical Care
      • 6.4.4.1. Company Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. B. Braun Medical Inc.
      • 6.4.5.1. Company Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Polymed
      • 6.4.6.1. Company Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Laminate Medical Technologies Ltd.
      • 6.4.7.1. Company Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Cook Group
      • 6.4.8.1. Company Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. Smiths Group plc
      • 6.4.9.1. Company Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. arteriovenous fistula devices market, by type, 2021 - 2033 (USD Million)
  • Table 3 U.S. arteriovenous fistula devices market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. arteriovenous fistula devices market revenue, 2021 - 2033 (USD Million)
  • Fig. 10 U.S. arteriovenous fistula devices market snapshot
  • Fig. 11 U.S. arteriovenous fistula devices market driver impact
  • Fig. 12 U.S. arteriovenous fistula devices market restraint impact
  • Fig. 13 U.S. arteriovenous fistula devices type key takeaways (USD Million)
  • Fig. 14 U.S. arteriovenous fistula devices market: type movement analysis
  • Fig. 15 AVF creation devices market, 2021 - 2033 (USD Million)
  • Fig. 16 AVF monitoring devices market, 2021 - 2033 (USD Million)
  • Fig. 17 AVF maintenance devices market, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. arteriovenous fistula devices market by end use key takeaways, (USD Million)
  • Fig. 19 U.S. arteriovenous fistula devices market: by end use movement analysis
  • Fig. 20 Hospitals market, 2021 - 2033 (USD Million)
  • Fig. 21 Ambulatory surgical centers market, 2021 - 2033 (USD Million)
  • Fig. 22 Dialysis centers market, 2021 - 2033 (USD Million)